Tourbillon Capital Partners’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-850,000	Closed	-$11.8M	–	45
2017 Q2	$11.8M	Buy	850,000 +440,000	+107%	+$6.09M	0.23%	35
2017 Q1	$6.15M	Buy	+410,000	New	+$6.15M	0.16%	37